文献速递白血病

年轻患者中的一种老白血病——儿童慢性髓性白血病的遗传学特征

An old leukaemia in young patients-Genetic characteristics of paediatric chronic myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2025-09-08

儿童慢性髓性白血病(CML)占儿童白血病的2%、青少年的9%,虽均携带BCR::ABL1融合基因,但生物学与临床特征可能不同于成人。儿童常起病更具侵袭性、治疗反应模式独特,近期基因组与转录组研究提示造血相关基因胚系变异更常见、细胞遗传学改变独特、BCR与ABL1断裂点呈年龄特异性分布;ASXL1等体细胞突变在部分儿童初诊时可见,但其预后意义尚不明确。

要点

  • 儿童CML占儿童白血病2%、青少年9%,均以BCR::ABL1融合基因为标志。
  • 儿童常起病更具侵袭性,治疗反应模式与成人不同。
  • 儿童CML造血相关基因胚系变异更常见,BCR与ABL1断裂点分布呈年龄特异性。

核心结论

  • 儿童CML可能是一种生物学上独特的疾病,而非成人CML的年轻形式。
  • 为推进风险分层和制定年龄特异性治疗策略,亟需更大规模国际研究和全面基因组分析。

研究设计与样本

  • 本文为综述,汇总儿童CML的遗传学与临床特征相关研究证据。

主要发现

  • 儿童CML占儿童白血病2%、青少年9%。
  • 儿童常起病更具侵袭性,治疗反应模式独特。
  • 儿童CML造血相关基因胚系变异更常见,并存在独特细胞遗传学改变及年龄特异性BCR与ABL1断裂点分布。
  • 儿童CML干细胞转录组分析显示差异表达特征,提示存在不同信号网络。
  • 部分儿童初诊时可见体细胞突变(尤其ASXL1),但其预后意义尚不明确。

关键数值与推荐

  • BCR::ABL1转录本亚型已知影响成人无治疗缓解,但其在儿童CML中的作用仍不明确。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • ASXL1等体细胞突变的预后意义尚不明确。
  • BCR::ABL1转录本亚型在儿童CML中的作用仍不明确。
  • 原文指出亟需更大规模国际研究和全面基因组分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic myeloid leukaemia (CML) accounts for 2% of leukaemias in children and 9% in adolescents. While the BCR::ABL1 fusion gene remains a hallmark across all age groups, emerging evidence suggests that paediatric CML exhibits unique biological and clinical characteristics compared to its adult counterpart. Children often present with more aggressive clinical features and show distinct treatment response patterns. Recent genomic and transcriptomic studies have highlighted a higher prevalence of germline variants in haematopoiesis-related genes and unique cytogenetic alterations, as well as age-specific distributions of BCR and ABL1 breakpoints. Transcriptomic profiling of paediatric CML stem cells reveals differential expression signatures that suggest the presence of distinct signalling networks. Somatic mutations-particularly in ASXL1-are observed at diagnosis in some children, though their prognostic relevance remains uncertain. Additionally, while the BCR::ABL1 transcript subtype is known to affect treatment-free remission in adults, its role in paediatric CML is still unclear. Collectively, these findings support the notion that paediatric CML may constitute a biologically distinct disease rather than simply a younger form of adult CML. To advance risk stratification and develop age-specific treatment approaches, larger international studies and comprehensive genomic analyses are urgently needed.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Metzler M, Branford S, Hijiya N, et al. An old leukaemia in young patients-Genetic characteristics of paediatric chronic myeloid leukaemia. Br J Haematol. 2025. PMID: 40921705. doi:10.1111/bjh.70134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。